相关实验视频
Updated: Jul 5, 2025

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
通过激活BMP4信号传递,AEBP1促进了乳头甲状腺癌的进展
Gaoda Ju1, Tao Xing2, Miaomiao Xu3
1Department of Medical Oncology, Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing 100142, China; Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Sciences & PUMC, Beijing 100730, China; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing 100730, China.
脂肪细胞增强剂结合蛋白1 (AEBP1) 通过促进上皮-甲状腺介质过渡 (EMT) 来驱动乳头甲状腺癌 (PTC) 的进展和转移. 针对AEBP1-骨形态遗传蛋白4 (BMP4) 轴为先进的PTC提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- 乳头甲状腺癌 (PTC) 是最常见的内分泌癌症.
- 晚期或转移性PTC呈现出不良的预后,表皮细胞-介质细胞过渡 (EMT) 导致转移,治疗抵抗和复发.
- 了解EMT的分子机制对于开发有针对性的PTC疗法至关重要.
研究的目的:
- 确定参与PTC进展和EMT的关键转录因子 (TF).
- 阐明脂肪细胞增强剂结合蛋白1 (AEBP1) 在PTC转移中的作用.
- 调查PTC中AEBP1-介导的调节途径.
主要方法:
- 生物信息学分析用于选关键的TF.
- 在体外实验 (细胞培养,基因淘汰) 以评估AEBP1功能.
- 在体内异种移植模型评估AEBP1在瘤生长和转移中的作用.
- RNA测序,双化酶记者测定和染色体免疫沉测定以确定下游目标.
主要成果:
- 在PTC中,AEBP1被确定为促进EMT和瘤进展的TF.
- AEBP1淘汰抑制了PTC细胞的生长,入侵和EMT标志物表达 (N-cadherin,TWIST1,ZEB2).
- 在异种移植模型中,AEBP1淘汰抑制了瘤生长和肺转移.
- 骨形态遗传蛋白4 (BMP4) 被确定为AEBP1.1的直接下游目标.
- 过度表达BMP4挽救了AEBP1淘汰对PTC细胞表型的抑制作用.
结论:
- 通过EMT,AEBP1显著促进PTC进展和转移.
- AEBP1-BMP4信号轴是PTC中的一个关键调节器.
- AEBP1-BMP4轴代表了先进的乳头甲状腺癌治疗的有前途的治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

